|
RRAGB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.77369999996036E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84686999999961E-05 |
| Normal-vs-Stage2 |
3.198500E-03 |
| Normal-vs-Stage3 |
7.804700E-04 |
| Normal-vs-Stage4 |
3.72079999999553E-06 |
| Stage1-vs-Stage2 |
9.114600E-01 |
| Stage1-vs-Stage3 |
4.334600E-01 |
| Stage1-vs-Stage4 |
1.210230E-01 |
| Stage2-vs-Stage3 |
5.056600E-01 |
| Stage2-vs-Stage4 |
8.868400E-02 |
| Stage3-vs-Stage4 |
3.604200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.45379999999074E-05 |
| Normal-vs-AfricanAmerican |
1.404830E-04 |
| Normal-vs-Asian |
1.541520E-03 |
| Caucasian-vs-AfricanAmerican |
6.548200E-01 |
| Caucasian-vs-Asian |
4.008800E-01 |
| AfricanAmerican-vs-Asian |
3.907800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.49200000027139E-07 |
| Normal-vs-Female |
4.789900E-02 |
| Male-vs-Female |
1.171880E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.591100E-04 |
| Normal-vs-Extreme_Weight |
9.54349999999771E-05 |
| Normal-vs-Obese |
1.136870E-03 |
| Normal-vs-Extreme_Obese |
1.836250E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.412000E-01 |
| Normal_Weight-vs-Obese |
5.648200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.382800E-01 |
| Extreme_Weight-vs-Obese |
6.486800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.545800E-01 |
| Obese-vs-Extreme_Obese |
2.497200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.278400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.171600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.55200999999439E-05 |
| Normal-vs-Age(81-100Yrs) |
2.752900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.385800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.522200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.259200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.621400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.140000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.068200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.823900E-04 |
| Normal-VS-Type2 PRCC |
4.40599999818048E-08 |
| Normal-VS-KIRP CIMP |
7.017600E-04 |
| Normal-VS-Unclassified PRCC |
9.79300000000238E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.003400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.336960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.372810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.084200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.617390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.766600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.56129999934396E-08 |
| Normal-vs-N1 |
1.346180E-02 |
| Normal-vs-N2 |
1.064310E-03 |
| N0-vs-N1 |
2.675000E-01 |
| N0-vs-N2 |
4.640200E-01 |
| N1-vs-N2 |
3.392400E-01 |
|
|
